AGP Executive Report
Last update: 4 hours agoTransplant Breakthrough: Hansa Biopharma says its US Phase 3 ConfIdeS kidney-transplant results have been accepted as a late-breaking oral abstract at the American Transplant Congress in Boston, with 12-month eGFR and safety data for highly sensitized patients using imlifidase. Liechtenstein Finance Focus: In Vaduz, Prime Minister Brigitte Haas told finance leaders that stability and continuity must stay central as regulation, geopolitics, tech change, and talent competition reshape the sector. Nordic-India Momentum: Modi’s Oslo push with Norway, Sweden, Finland, Iceland and Denmark is framed as a major strategic pivot—covering green transition, digital and AI, energy security, and research—while also drawing attention to how the West views India. EU Health Approvals: Merck won a positive EU CHMP opinion for KEYTRUDA plus Padcev in cisplatin-ineligible muscle-invasive bladder cancer, and Pharming secured EU marketing authorization for Joenja (leniolisib) for APDS. Travel Rules Tighten: Thailand cut most visa-free stays back to 30 days, citing overstays, crime, and security concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
